Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Valentini

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
American Journal of Therapeutics|May 23, 2008
Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trialJohn E A Blair, Cezar Macarie, Witold Ruzyllo, et al.
Small Science|May 11, 2026
Neuroprotective Effects of Cerium Oxide Nanoparticles During SpaceflightAlessio Carmignani, Attilio Marino, Matteo Battaglini, et al.
Journal of the American College of Cardiology|June 7, 2008
Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failureMihai Gheorghiade, John E A Blair, Gerasimos S Filippatos, et al.
NPJ Microgravity|October 3, 2024
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissueEster Sara Di Filippo, Sara Chiappalupi, Stefano Falone, et al.
Science Translational Medicine|November 26, 2010
Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studiesChiara Lanzani, Lorena Citterio, Nicola Glorioso, et al.
American Heart Journal|May 26, 2009
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trialSanjiv J Shah, John E A Blair, Gerasimos S Filippatos, et al.
Pharmacogenomics|October 7, 2005
OASIS-HT: design of a pharmacogenomic dose-finding studyJan A Staessen, Tatiana Kuznetsova, Rok Acceto, et al.
Journal of the Association for Research in Otolaryngology : JARO|September 13, 2024
Otoacoustic Estimate of Astronauts' Intracranial Pressure Changes During SpaceflightArturo Moleti, Triestino Minniti, Yoshita Sharma, et al.
Trials|January 18, 2011
Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxinJan A Staessen, Lutgarde Thijs, Katarzyna Stolarz-Skrzypek, et al.
Plos Medicine|March 6, 2020
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient dataXin Hui S Chan, Yan Naung Win, Ilsa L Haeusler, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
American Journal of Therapeutics|May 23, 2008
Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trialJohn E A Blair, Cezar Macarie, Witold Ruzyllo, et al.
Small Science|May 11, 2026
Neuroprotective Effects of Cerium Oxide Nanoparticles During SpaceflightAlessio Carmignani, Attilio Marino, Matteo Battaglini, et al.
Journal of the American College of Cardiology|June 7, 2008
Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failureMihai Gheorghiade, John E A Blair, Gerasimos S Filippatos, et al.
NPJ Microgravity|October 3, 2024
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissueEster Sara Di Filippo, Sara Chiappalupi, Stefano Falone, et al.
Science Translational Medicine|November 26, 2010
Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studiesChiara Lanzani, Lorena Citterio, Nicola Glorioso, et al.
American Heart Journal|May 26, 2009
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trialSanjiv J Shah, John E A Blair, Gerasimos S Filippatos, et al.
Pharmacogenomics|October 7, 2005
OASIS-HT: design of a pharmacogenomic dose-finding studyJan A Staessen, Tatiana Kuznetsova, Rok Acceto, et al.
Journal of the Association for Research in Otolaryngology : JARO|September 13, 2024
Otoacoustic Estimate of Astronauts' Intracranial Pressure Changes During SpaceflightArturo Moleti, Triestino Minniti, Yoshita Sharma, et al.
Trials|January 18, 2011
Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxinJan A Staessen, Lutgarde Thijs, Katarzyna Stolarz-Skrzypek, et al.
Plos Medicine|March 6, 2020
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient dataXin Hui S Chan, Yan Naung Win, Ilsa L Haeusler, et al.
Pageof 3